Form 4: BrightSpring Health Services Officer Jennifer Yowler Reports Acquisition of Restricted Stock Units and Stock Options
SEC Form 4 Filing
Jennifer Yowler, President of PharMerica at BrightSpring Health Services, reports the acquisition of restricted stock units and stock options.
Summary
- On March 17, 2025, Jennifer Yowler, President of PharMerica at BrightSpring Health Services, reported the acquisition of 23,029 shares of common stock through restricted stock units (RSUs) and 48,900 stock options.
- The RSUs vest in three equal annual installments commencing on January 25, 2026, with each RSU representing a contingent right to receive one share of common stock upon settlement.
- The stock options, with an exercise price of $17.45, also vest in three equal annual installments commencing on January 25, 2026, and expire on March 17, 2035.
- Following these transactions, Yowler directly owns 75,401 shares of BrightSpring Health Services common stock, including shares underlying RSUs.
- Yowler has also granted power of attorney to Jon Rousseau, Jennifer Phipps, and Allison Brown to handle SEC filings on her behalf.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing compensation. The acquisition of RSUs and stock options could be seen as a positive sign of confidence, but it's a routine event.
Positives
- The acquisition of RSUs and stock options suggests confidence in the company's future performance from an insider perspective.
Future Outlook
The vesting schedules for the RSUs and stock options indicate a multi-year incentive structure for the reporting person.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. This filing indicates changes in beneficial ownership by a company officer.
Comparison to Industry Standards
- Equity compensation in the form of RSUs and stock options is a common practice among publicly traded companies to align management's interests with those of shareholders.
- Vesting schedules of three years are typical for such grants, incentivizing long-term performance and retention.
- Comparable companies such as Option Care Health and CVS Health also utilize similar equity compensation strategies for their executives.
Stakeholder Impact
- The grant of RSUs and stock options can align the interests of management with those of shareholders, potentially leading to increased shareholder value.
Key Dates
| Date | Description |
|---|---|
| 2024-10-29 | Date of execution of Power of Attorney. |
| 2025-03-17 | Date of transaction: Grant of RSUs and stock options. |
| 2025-03-19 | Date of signature for the Form 4 filing. |
| 2026-01-25 | Commencement date for vesting of RSUs and stock options. |
| 2035-03-17 | Expiration date of stock options. |
Keywords
Form 4, BrightSpring Health Services, Jennifer Yowler, PharMerica, RSU, Stock Options, Beneficial Ownership, Insider Trading, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.